APA (7th ed.) Citation

Xiao, X., Chen, P., Zhong, Y., Luo, X., Liu, Y., Lu, Y., . . . Liu, H. (2023). Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy. Cancer Medicine, 12(22), 20838. https://doi.org/10.1002/cam4.6657

Chicago Style (17th ed.) Citation

Xiao, Xibin, et al. "Outcomes and Risk Factors of SARS‐CoV‐2 Omicron Variant in B‐cell Lymphoma Patients Following CD19 Targeted CAR‐T Therapy." Cancer Medicine 12, no. 22 (2023): 20838. https://doi.org/10.1002/cam4.6657.

MLA (9th ed.) Citation

Xiao, Xibin, et al. "Outcomes and Risk Factors of SARS‐CoV‐2 Omicron Variant in B‐cell Lymphoma Patients Following CD19 Targeted CAR‐T Therapy." Cancer Medicine, vol. 12, no. 22, 2023, p. 20838, https://doi.org/10.1002/cam4.6657.